TrialBMC cancer2021

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).

E Tagkalos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.